Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives
James E Neffendorf, Timothy L Jackson Department of Ophthalmology, School of Medicine, King’s College London, London, United Kingdom Abstract: Neovascular age-related macular degeneration is a leading cause of blindness in the developed world. Currently, the treatment of choice is intrav...
Guardado en:
Autores principales: | Neffendorf JE, Jackson TL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/02e5ba0f0a98414db52aa02139552559 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Patients’ knowledge and perspectives on wet age-related macular degeneration and its treatment
por: Sushma Kandula, et al.
Publicado: (2010) -
Evaluation of cardiovascular biomarkers in patients with age-related wet macular degeneration
por: Keles S, et al.
Publicado: (2014) -
Age-related macular degeneration: current treatments
por: Jean Pierre Hubschman, et al.
Publicado: (2009) -
Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration [Corrigendum]
por: Dervenis N, et al.
Publicado: (2016) -
Spectral domain OCT versus time domain OCT in the evaluation of macular features related to wet age-related macular degeneration
por: Isola V, et al.
Publicado: (2012)